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Non-Gaussianity index (λ) is a new index of heart rate variability (HRV) that character-
izes increased probability of the large heart rate deviations from its trend. A previous
study has reported that increased λ is an independent mortality predictor among patients
with chronic heart failure. The present study examined predictive value of λ in patients
after acute myocardial infarction (AMI). Among 670 post-AMI patients, we performed 24-h
Holter monitoring to assess λ and other HRV predictors, including SD of normal-to-normal
interval, very-low frequency power, scaling exponent α1 of detrended ﬂuctuation analysis,
deceleration capacity, and heart rate turbulence (HRT). At baseline, λ was not correlated
substantially with other HRV indices (|r |< 0.4 with either indices) and was decreased in
patients taking β-blockers (P = 0.04). During a median follow-up period of 25months, 45
(6.7%) patients died (32 cardiac and 13 non-cardiac) and 39 recurrent non-fatalAMI occurred
among survivors. While all of these HRV indices but λ were signiﬁcant predictors of both
cardiac and non-cardiac deaths, increased λ predicted exclusively cardiac death (RR [95%
CI], 1.6 [1.3–2.0] per 1 SD increment, P< 0.0001). The predictive power of increased λ
was signiﬁcant even after adjustments for clinical risk factors, such as age, diabetes, left
ventricular function, renal function, prior AMI, heart failure, and stroke, Killip class, and
treatment ([95% CI], 1.4 [1.1–2.0] per 1 SD increment, P = 0.01). The prognostic power of
increased λfor cardiac death was also independent of all other HRV indices and the com-
bination of increased λ and abnormal HRT provided the best predictive model for cardiac
death. Neither λ nor other HRV indices was an independent predictor of AMI recurrence.
Among post-AMI patients, increased λ is associated exclusively with increased cardiac
mortality risk and its predictive power is independent of clinical risk factors and of other
HRV predictors.
Keywords: heart rate variability, myocardial infarction, ambulatory ECG, sudden cardiac death, mortality, non-
Gaussianity, prospective study, ENRICHD study
INTRODUCTION
Experimental models for sudden cardiac death after myocardial
infarction (AMI) indicate that sympathetic stimulation under
impaired reﬂex vagal antagonism provokes ventricular vulnerabil-
ity to ﬁbrillation during transient myocardial ischemia (Schwartz
et al., 1984; Vanoli et al., 1991). Usefulness of the detection of
Abbreviations: AC, acceleration capacity; AMI, acute myocardial infarction; CI,
conﬁdence interval; DC, deceleration capacity; DFA, detrended ﬂuctuation analy-
sis; ENRICHD, enhancing recovery in coronary heart disease; HF, high frequency;
HRT, heart rate turbulence; HRV, heart rate variability; IRQ, inter quartile range;
LF, low frequency; LF/HF, LF-to-HF ratio; PDF, probability density function; RR,
relative risk; SD, standard deviation; SDNN, SD of all normal-to-normal intervals;
TO, turbulence onset; TS, turbulence slope; ULF, ultra-low frequency;VLF, very-low
frequency.
autonomic dysfunction by heart rate variability (HRV) has been
proposed for post-AMI risk stratiﬁcation (Kleiger et al., 1987;
La Rovere et al., 1998; Schmidt et al., 1999; Bauer et al., 2006).
Most of HRV indices proposed, however, primarily reﬂect reduced
or impaired vagal function (Camm et al., 1996; Marine et al.,
2002; Bauer et al., 2006). In contrast, few HRV indices have been
related to sympathetic function and their prognostic signiﬁcance is
still uncertain. For example, a decrease in low-frequency-to-high-
frequency ratio, but not its increase, is associated with increased
risk of mortality (Tsuji et al., 1994; Huikuri et al., 2000).
As a marker potentially related to sympathetic cardiac over-
drive, we have recently proposed increased non-Gaussianity of
HRV (Kiyono et al., 2008). Non-Gaussianity has been used in ﬂuid
dynamics for characterizing intermittency of turbulence (Castaing
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et al., 1990). When applied to analysis of HRV, it captures the
occurrence of intermittent heart rate increments (Kiyono et al.,
2004, 2007). In a cohort of chronic heart failure (Kiyono et al.,
2008),we previously observed that the increased non-Gaussianity
of HRV predicts increased risk of mortality, while none of the
conventional HRV indices were predictive of death among these
patients. In the present study, we sought to determine if increased
non-Gaussianity of HRV in post-AMI patients is also associated
with their increased mortality risk independent of clinical risk
factors and of the established HRV predictors.
MATERIALS AND METHODS
STUDY PATIENTS
Patients admitted to the coronary care units of four of the eight
clinical trial sites (Washington University, St. Louis, MO, USA;
Duke University, Durham, NC, USA; Harvard University, Boston,
MA,USA;Yale University, New Haven, CT,USA) of the enhancing
recovery in coronary heart disease (ENRICHD) study (Berkman
et al., 2003) for an attack of AMI between October 1997 and Jan-
uary 2000 were enrolled in this substudy. AMI was diagnosed
if a patient had at least 2 of the following ﬁndings: chest pain
for ≥20min, creatine kinase >200U/L, and ST-segment eleva-
tion of ≥0.1mV in two or more limb leads or ≥0.2mV in two
or more contiguous precordial leads at the time of admission.
The sample included 358 participants of the ENRICHD clinical
trial who scored 10 or higher on the Beck Depression Inven-
tory (BDI; Steeds et al., 2004) and 408 AMI control participants
who were not randomized in the ENRICHD trial because they
were not depressed (BDI< 10), but were otherwise medically eli-
gible for the trial. Patients were excluded if they: (1) had other
life-threatening illnesses; (2) were too ill or logistically unable to
participate; (3) had analyzable electrocardiographic data <22 h
or sinus rhythm <80% of total recorded beats in Holter mon-
itoring; (4) had atrial ﬁbrillation, atrial ﬂutter, or animplanted
pacemaker or deﬁbrillator; or (5) declined to provide informed
written consent.
MEASUREMENTS
Holter electrocardiograms were recorded for 24 h within 28
(median [inter quartile range, IQR], 13 [6–19]) days after the
index AMI. To assure standardization of the Holter recordings, we
used Marquette Model 8500 monitors at each site. Holter record-
ings were scanned at the Heart Rate Variability Core laboratory
at Washington University on a Marquette SXP Laser scanner with
software version 5.8 (Marquette Electronics) using standard pro-
cedures. The labeled beat ﬁle was exported to a personal computer
and a workstation for analysis of non-Gaussianity and other HRV
indices.
ANALYSIS OF NON-GAUSSIANITY INDEX
This analysis is designed to detect intermittency of heart rate
increment. The intermittent behavior of HRV is related to non-
Gaussian probability distribution with marked fat tails and a peak
around the mean value, indicative of a higher probability of the
interspersed appearance of large and small increments than the
Gaussian ﬂuctuations. To quantify such non-Gaussian behavior,
we calculated a non-Gaussianity index. The background and a
mathematical description of the non-Gaussianity index have been
reported previously (Kiyono et al., 2004, 2007). Brieﬂy, this index
has been derived from amethod for analyzingmulti-scale statistics
of complex ﬂuctuations, originally used for characterizing inter-
mittency of hydrodynamic turbulence (alternating transition of a
ﬂuid regime between laminar ﬂow and its breakdown into bursty
disorganized eddies, occurring in a seemingly random manner at
a variety of scales; Castaing et al., 1990).
The analysis of non-Gaussianity of HRV is divided into four
steps. In step 1, time series of normal-to-normal R–R intervals
are interpolated with a cubic spline function and resampled at an
interval (Δt ) of 250ms (4Hz), yielding interpolated time series
b(t ) (Figure 1). After subtracting average interval bave, integrated
time series B(t ) are obtained by integrating b(t ) over the entire
length,
B(t ) =
t/Δt∑
i=1
{b(iΔt ) − bave}.
In step 2, the local trend of {B(t )} is eliminated by third-order
polynomial that is ﬁt to {B(t )} within moving windows of length
2s, where s is the scale of analysis. In step 3, intermittent devi-
ation ΔsB(t ) is measured as the increment with a time lag s of
the detrended time series {B∗(t )}. For instance, in a window from
T− s to T+ s, the increments are calculated as
ΔsB(t ) = {B(t + s/2)− fﬁt(t + s/2)}−{B(t − s/2)− fﬁt(t − s/2)}
where T− s/2≤ t<T+ s/2 and fﬁt(t ) is the polynomial repre-
senting the local trend of B(t ), of which the elimination assures
the zero-mean probability density function in the next step. In
step 4, ΔsB is normalized by the SD to quantify the probability
density function (PDF). Then, the non-Gaussianity index λs is
estimated as
λs =
√
2
q(q − 2)
[
ln
(√
π〈|ΔsB|q〉
2q/2
)
− lnΓ
(
q + 1
2
)]
,
where <|ΔsB|q> denotes an estimated value of the q-th order
absolute moment of {ΔsB}. If the λs is close to zero, the observed
PDF is close to a Gaussian distribution. On the other hand, a
larger value of λs means that the observed PDF has fatter tails and
a sharper peak in comparison with the Gaussian distribution. This
λs was originally introduced as a parameter of a phenomenolog-
ical model to describe non-Gaussian distributions in the study of
intermittency of hydrodynamic turbulence (Castaing et al., 1990).
Kiyono et al. (2007) further showed that the λs can be estimated
by the above equation based on the q-th order absolute moment
of a time series independently of q.
In the present study, we calculated the λs based on the 0.25th
order moment (q= 0.25) to emphasize the center part of PDF and
to reduce the effects of large outliers such as those by ectopic
beats, if any, even after the correction. This implies that our
non-Gaussianity index with q = 0.25 more strongly characterize
speaked PDF around the center of the observed non-Gaussian dis-
tribution, differently from that with higher order moments, such
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FIGURE 1 | Representative examples of non-Gaussian heart rate
fluctuations with different values of λ25 s in post-AMI patients, survivor
(A) and cardiac death (B, C).Trend graphs of normal-to-normal sinus
rhythm interval (Top row), standardized time series of heart rate increments
{Δ25 sB(t )} (middle row), and standardized PDFs of heart rate increments
{Δ25 sB(t )} (bottom row). Estimated values of the non-Gaussianity index of
λ25 s are shown in each panel in the bottom row. In the solidline, we
superimposed the PDF approximated by a non-Gaussian model (Kiyono
et al., 2007) with the parameter λ25 s. The non-Gaussian model provides an
excellent approximation of the peaked PDF around center (particularly in the
gray shaded area covering ±3 SD) of the observed distribution, caused
mainly by intermittent alterations of quiet (laminar) phase and busty phase
(middle row), because our non-Gaussianity index with q =0.25 characterizes
peaked shape of the observed non-Gaussian distribution and reduces the
effects of extreme outliers, if any. The dashed lines represent the Gaussian
distribution (λ25 s →0).
as kurtosis based on the fourth moment, emphasizing heavy tails,
and extreme deviations. Also, we previously showed that the accu-
racy of estimation of λs for typical Holter records (data points,
n ≈ 105) is much higher when using q< 2, as compared to q> 2
(see Figure 3 of Kiyono et al., 2007). The C source codes and exe-
cutables for computing the non-Gaussianity index are available
online at www.ge.ce.nihon-u.ac.jp/∼kiyono/app/.
In the present study, we set the scale s at 25 s. In a previous
cohort study of chronic heart failure, we noted that λ40 beat > 0.6
had the best predictive power for mortality (Kiyono et al., 2008).
Because the λ40 beat is based on beat scale, could be affected by
both inter- and intra-individual differences in heart rate, we rean-
alyzed the previous data using time (s) as the unit of scale (see
Appendix). Then, we found that λ25 s was comparable to λ40 beat
in predictive power for mortality. We therefore used λ25 s as the
non-Gaussianity index and λ25 s > 0.6 as the cutoff threshold in
survival curve analyses.
ANALYSIS OF CONVENTIONAL HRV INDICES
We calculated the conventional indices of HRV that are recognized
as post-AMI risk predictors by the Task Force of the European
Society of Cardiology and the North American Society of Pacing
and Electrophysiology (Camm et al., 1996): mean N–N interval,
SD of all N–N intervals (SDNN), the variances corresponding
to ultra-low frequency (ULF; 0–0.0033Hz), very-low frequency
(VLF; 0.0033–0.04Hz), low frequency (LF; 0.04–0.15Hz) andhigh
frequency (HF; 0.15–0.40Hz) bands, and LF/HF. The variances
of these frequency components were transformed in the natural
logarithmic values (Ln).We examined the fractal correlation prop-
erties of heart rate dynamics using detrended ﬂuctuation analysis
(DFA) and calculated the short-term (4–11 beat) and long-term
(≥11 beats) scaling exponents as α1 and α2, respectively (Peng
et al., 1995). We also computed the deceleration and acceleration
capacity (DC and AC) by the phase rectiﬁed signal averaging of
the 24-h N–N interval time series (Bauer et al., 2006). Finally,
we assessed indices of heart rate turbulence (HRT; Schmidt et al.,
1999). In accordance with previous reports (Barthel et al., 2003;
Bauer et al., 2009), we deﬁned abnormal turbulence onset (TO) as
≥0%, abnormal turbulence slope (TS) as≤2.5ms/beat and abnor-
mal HRT as an instance when both TO and TS were abnormal. If
ventricular premature contractions suitable for calculating HRT
were ﬁve or less in the 24-h recording, the patients were classiﬁed
as having normal HRT.
ENDPOINT ANALYSIS
The end points of the present study were all-cause mortal-
ity and recurrent non-fatal AMI. Patients underwent follow-up
assessments 6months after study enrollment and annually there-
after for up to 30months. The end points were identiﬁed from
follow-up visits, telephone calls, routine hospital surveillance, and
contacts with patients’ physicians. The records of every identi-
ﬁed hospitalization were obtained for review and conﬁrmation.
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The ENRICHDECG core laboratory classiﬁed electrocardiograms
obtained during hospitalizations by the Minnesota code using ser-
ial change rules. Death certiﬁcates were obtained for all reported
deaths. The mortality endpoints used for the present study were
either cardiac deaths (AMI, cardiac failure, and sudden cardiac
death) or non-cardiac deaths. Sudden cardiac death was deﬁned
as unexpected death within 1 h after the onset of a new symptom,
or unexpected unwatched death.
STATISTICAL ANALYSIS
Cox proportional hazards regression analyses were used for deter-
mining the signiﬁcant predictors of mortality and recurrent non-
fatal AMI. The independent associations of predictors were eval-
uated with the multivariable hazards regression analysis adjusted
for the ENRICHD risk score, which is a weighted sum of all inde-
pendent risk factors for mortality in the ENRICHD trial (Jaffe
et al., 2006). Potential risk factors that were considered included
factors such as smoking, and medications, including beta blockers.
The ﬁnal risk score included age, diabetes, left ventricular ejection
fraction, creatinine level, prior AMI, history of pulmonary dis-
ease, prior transient ischemic attack or stroke,history of congestive
heart failure, Killip class at time of index AMI, and treatment with
vasodilators. The predictors of mortality were determined in the
entire subjects, while those of recurrent non-fatal AMI were deter-
mined within survivors. The survival curves were estimated by the
Kaplan–Meier method and compared using the Mantel–Haenszel
log-rank test.
The data are reported as the median and IQR for continu-
ous variables and counts and percentage for categorical variables
unless otherwise noted. Comparisons between groups were per-
formed by Chi-square test for categorical variables and one-way
analysis of variance for continuous variables with Tukey’s Studen-
tized range test for multiple comparisons. Pearson’s correlation
coefﬁcient (r) was used to evaluate correlations between different
variables and an |r |≥ 0.4 was interpreted to show a substantial
correlation. We judged a P value of less than 0.05 to be signiﬁcant.
RESULTS
Holter electrocardiograms were analyzable in 670 out of 766 eligi-
ble patients (88%). The 96 excluded patients were medically and
demographically similar to those included, except that they were
more likely to have diabetes and less likely to be currently smoking.
Table 1 shows the clinical characteristics of the 670 patients. β-
Blockers were prescribed at the Holter monitoring in 556 patients
(83%).
HRV AND NON-GAUSSIANITY INDICES
The HRV indices that are considered as relating to cardiac vagal
function were highly correlated with each other, while the non-
Gaussianity index of λ25 s showed no substantial correlations with
these indices (Table 2). Also,λ25 s correlatedwith neither the num-
ber of ventricular ectopies per 24 h (r =− 0.01) nor its products
with TO or TS (r = 0.01,− 0.07), indicating that λ25 s is unrelated
to heart rate ﬂuctuations accompanying ventricular arrhythmias
(“HRT”). On the other hand, λ25 s was lower in patients taking β
blockers than in those not taking (mean [SD], 0.53 [0.12], and 0.56
[0.13], respectively,P = 0.04). No such effect onλ25 s was observed
Table 1 | Characteristics of patients.
Number of patients, n 670
OUTCOME
Follow-up (days), median (IQR) 748 (556–947)
Cardiac death 32 (4.8%)
Non-cardiac death 13 (1.9%)
Non-fatal AMI 57 (8.5%)
CLINICAL AND DEMOGRAPHIC CHARACTERISTICS
Age (years), median (IQR) 59 (51–68)
Women 270 (40%)
Body mass index (kg/m2), median (IQR) 28.1 (25.2–31.9)
Hypertension 140 (21%)
Diabetes mellitus 189 (28%)
Current smoker 220 (33%)
History of myocardial infarction 141 (21%)
History of coronary bypass surgery 72 (11%)
LVEF (%), median (IQR) 48 (25–55)
LVEF>35% 388 (58%)
Creatinine (mg/dL), median (IQR) 1.0 (0.8–1.2)
Beck Depression Inventory score, median (IQR) 8 (3–15)
CHARACTERISTICS OF INDEX MI
Killip class III–IV 34 (5.1%)
Anterior wall AMI 219 (33%)
Inferior wall AMI 302 (45%)
TREATMENT
β-Blockers 556 (83%)
Angiotensin converting enzyme inhibitors 320 (48%)
Aspirin 602 (90%)
Calcium channel blockers 96 (14%)
Thrombolytic therapy after AMI 210 (31%)
Coronary bypass after AMI 89 (13%)
Coronary angioplasty <24h after AMI 419 (63%)
Acute reperfusion ≤12h after AMI 307 (47%)
AMI, acute myocardial infarction; IQR, inter quartile range.
for angiotensin converting enzyme inhibitors, aspirin, or calcium
channel blockers.
INCREASED NON-GAUSSIANITY AND PROGNOSIS
During follow-up for a median of 25months, 45 (6.7%) patients
died, with 32 deaths classiﬁed as cardiac and 13 as non-cardiac
deaths, and39(6.2%)patients among survivors had recurrent non-
fatal AMI. On average, all HRV indices including λ25 s and HRT
category showed no signiﬁcant difference between survivors with
and without recurrent non-fatal AMI (Figure 2). SDNN, lnVLF,
DFA α1 and DC were lower and abnormal HRT was more preva-
lent in patients suffering both cardiac death and non-cardiac death
compared to survivors, whereas λ25 s was greater only in the car-
diac death patients. The typical relationships between λ25 s and
other HRV indices are shown in Figure 3. The surviving patient
(Figure 3A) showed large N–N interval variability, while both
cardiac (Figure 3B) and non-cardiac (Figure 3C) death patients
showed decreased variability. Figure 3D shows standardized PDFs
of heart rate increment constructed from the same data. The
Frontiers in Physiology | Computational Physiology and Medicine September 2011 | Volume 2 | Article 65 | 4
Hayano et al. Heart rate intermittency
Table 2 | Correlations among HRV indices, HRT, and λ25 s.
Variable SDNN LnVLF DFA α1 DC TO TS λ25 s
Mean N–N 0.58 0.57 0.18 0.50 −0.17 0.37 −0.05
SDNN – 0.85 0.23 0.61 −0.33 0.41 −0.02
LnULF 0.93 0.80 0.30 0.58 −0.30 0.36 −0.08
LnVLF 0.85 – 0.45 0.71 −0.35 0.44 −0.15
LnLF 0.83 0.91 0.38 0.70 −0.36 0.47 −0.06
LnHF 0.77 0.73 −0.09 0.56 −0.26 0.38 0.06
LF/HF 0.00 0.16 0.72 0.12 −0.10 0.12 −0.13
DFA α1 0.23 0.45 – 0.43 −0.20 0.23 −0.17
DFA α2 −0.26 −0.41 −0.21 −0.34 0.15 −0.30 −0.19
AC 0.66 0.72 0.35 0.92 −0.37 0.53 −0.34
DC 0.61 0.71 0.43 – −0.38 0.52 −0.33
TO −0.33 −0.35 −0.20 −0.38 – −0.28 0.16
TS 0.41 0.44 0.23 0.52 −0.28 – −0.15
Values are correlation coefﬁcients (|r|>0.4 are shaded). Abbreviations for HRV indices are deﬁned in the text.
surviving and non-cardiac death patients showed similar PDF
curves and comparable λ25 s (0.40 and 0.44, respectively) despite
the large difference in absolute variability. In contrast, the cardiac
death patient showed a PDF curve with a more tapered center and
fatter tails with a λ25 s of 0.80.
The unadjusted Cox hazards regression analysis revealed that
decreases in SDNN and DC were increased risk of recurrent non-
fatal AMI, while DFA α1, HRT, and λ25 s had no predictive power
for the recurrence (Table 3). All HRV indices but λ25 s and abnor-
mal HRT predicted increased risk of both cardiac and non-cardiac
death, while increased λ25 s predicted increased risk of only car-
diac death but not of non-cardiac death. The associations of λ25 s
and other HRV indices with mortality risk remained signiﬁcant
even after adjustment for the ENRICHD risk score, while the
associations of HRV indices with AMI recurrence were no longer
signiﬁcant (Table 3).
The predictive power of λ25 s for cardiac deathwas independent
of theotherHRV indices. Increasedλ25 s was a signiﬁcant predictor
in the models including either HRV predictors (Table 4). Among
these models, the risk of cardiac death was best predicted by the
combination of increased λ25 s and abnormal HRT (Table 4).
We therefore generated Kaplan–Meier curves for this combina-
tion along with those for λ25 s dichotomized at 0.6 (Figure 4).
As expected, mortality was highest in the patients who had both
increased λ25 s and abnormal HRT. More importantly, however,
mortality was low not only in patients who had neither of the two
factors but also was low in those who had either one factor alone,
suggesting that these factors acted synergistically.
DISCUSSION
We assessed non-Gaussianity of HRV in post-AMI patients and
found that increased non-Gaussianity index of λ25 s predicts risk
of cardiac death in these patients. The λ25 s showed no substantial
correlation with HRV indices reﬂecting cardiac vagal functions
and was decreased in patients taking β-blockers. While the other
HRV indices were associated with both cardiac and non-cardiac
deaths, the increased λ25 s was associated exclusively with cardiac
death but not with non-cardiac death. The predictive power of
increased λ25 s was independent of clinical risk factors and of the
other HRV predictors. The survival curve analyses revealed that
increased λ25 s and abnormal HRT have a synergistic effect on the
risk of cardiac mortality. Additionally, λ25 s showed no predictive
power for the recurrence of non-fatal AMI, suggesting that λ25 s
may not be associated with the mechanisms developingAMI itself.
The non-Gaussianity of heart rate has several unique features
that had been undetected by conventional indices of HRV. First,
λ25 s is unrelated to the cardiac autonomic responsiveness reﬂected
in the magnitude of HRV. As shown in Figure 3, surviving and
non-cardiac death patients exhibited comparable λ25 s despite a
large difference in other HRV indices. Second,λ25 s captures inter-
mittent heart rate increments within a scale of 25 s. Although the
heart rate ﬂuctuations in this scale are mediated almost exclusively
by neural autonomic activities (Camm et al., 1996), λ25 s showed
no substantial correlation with the HRV indices reﬂecting vagal
heart rate regulation and was decreased in patients taking β block-
ers. Thus, λ25 s is likely to capture heart rate ﬂuctuation mediated
by intermittent activations of cardiac sympathetic activity at least
partly. Third,λ25 s is independent of heart rate ﬂuctuations caused
by ectopic beats, i.e., HRT (Schmidt et al., 1999). Indeed, λ25 s
showed no signiﬁcant correlation with the number of ventricular
ectopies per 24 h or its products with TO or TS. Additionally, λ25 s
is also independent of erratic rhythms detected by Poincare plot
(Woo et al., 1992; Stein et al., 2005), because beat-to-beat changes
in N–N intervals are averaged out when calculating λ25 s (Kiyono
et al., 2008).
The present study indicates that the risk of mortality is par-
ticularly high in the presence of increased λ25 s and abnormal
HRT compared with the presence of only one alone. This syner-
gistic effect between λ25 s and HRT is compatible with a patho-
physiologic paradigm for post-AMI sudden cardiac death; i.e.,
sympathetic stimulation under impaired reﬂex vagal antagonism
precipitates ventricular ﬁbrillation during transient myocardial
ischemia in the heart with healed AMI (Schwartz et al., 1984;
Vanoli et al., 1991). The increased λ25 s appears to detect frequent
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FIGURE 2 | Heart rate variability indices, HRT, and non-Gaussianity
index (λ25 s) in post-AMI patients grouped by the endpoint of
follow-up: MF, recurrent AMI-free survival; RM, recurrent non-fatal AMI;
CD, cardiac death; and NCD, non-cardiac death. For box plots, upper and
lower boundaries of the box indicate the 75th and 25th percentiles and a
line within the box marks the median.Whiskers above and below the box
indicate the 90th and 10th percentiles and dots above and below the
whiskers indicate 95th and 5th percentiles. P values show signiﬁcance of
ANOVA except for abnormal HRT, for which bar graphs show percentage of
patients who showed abnormal HRT and P value indicates the signiﬁcance
of chi-square test. *Signiﬁcantly different from the value for recurrent
AMI-free survivors (Tukey’s Studentized range test).
sympathetic activations and the abnormalHRT to reﬂect impaired
reﬂex vagal antagonism. The absence of the association of λ25 s
with the AMI recurrence also supports the hypothesis, suggesting
that the increased λ25 s maybe associated with the mechanisms
precipitating cardiac death after AMI rather than those deve-
loping AMI.
The present ﬁndings also indicate that λ25 s is unrelated to
the risk of non-cardiac death. This ﬁnding was not observed for
FIGURE 3 |Trend graphs of 24-h N–N interval in three representative
patients, recurrent AMI-free survivor (A), cardiac death (B) and
non-cardiac death (C), and their standardized PDF of intermittent heart
rate increments (D). Insets of panels (A–C) show values of HRV indices
obtained from each N–N interval time series. In panel (D), the Gaussian
distribution (λ25 s =0), an inverted parabola in this semi-log plot without
“tapered” centers and “fat” tails, is shown as a dashed line. Abbreviations
for HRV indices are deﬁned in the text.
the other HRV indices. Decreased HRV is associated with various
health conditions (Priori et al., 2001), including diabetes, uremia,
alcoholism, obesity, smoking, depression, and aging (Malik and
Camm, 2004) and with mortality among general elderly popu-
lations (Tsuji et al., 1994), which may explain the non-speciﬁc
associations of decreased HRV with increased risk for all – cause
mortality (Kleiger et al., 1987; La Rovere et al., 1998; Schmidt
et al., 1999; Bauer et al., 2006). The selective associations of
increased λ25 s with cardiac death seems useful for predicting
patients who would beneﬁt from preventive approaches, such
as those with implantable cardioverter deﬁbrillators (Moss et al.,
2002).
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Table 4 | Independent relative risk of λ25 s for post-AMI cardiac
mortality.
Prediction
model
λ25 s Model fit (likeli-
hood ratio test)
Adjusted RR
(95% CI)
P χ2 P
SDNN+λ25 s 1.4 (1.1–1.7) 0.007 21.6 <0.0001
LnVLF+λ25 s 1.3 (1.0–1.6) 0.04 22.6 <0.0001
DFA
α1 +λ25 s
1.4 (1.1–1.8) 0.007 17.3 <0.0001
DC+λ25 s 1.3 (1.0–1.7) 0.01 22.5 <0.0001
Abnormal
HRT+λ25 s
1.3 (1.0–1.6) 0.02 45.0 <0.0001
CI, conﬁdence interval; RR, relative risk.
Adjusted RRs represent those for 1 SD (0.13) increment in λ25 s.
STUDY LIMITATIONS
Our study has several limitations. First, the sample included a sub-
set of patients enrolled in the ENRICHD trial who had elevated
symptoms of depression, which could affect the generalizability of
our results.However, the proportion of the depressed patientswith
BDI scores≥ 10 was 47%, which is comparable to the reported
prevalence of depression (45–47%) in general post-AMI popula-
tions (Schleifer et al., 1989; Steeds et al., 2004). Second, we did not
consider sudden cardiac death as a separate endpoint because the
causes of cardiac death were not subcategorized in the record of
ENRICHD study. Furthermore, the number of deaths, particularly
that of non-cardiac death was small (13) and the power to detect a
possible associationbetweenλ25 s andnon-cardiac deathwas inad-
equate. Finally, to establish the λ25 s as a clinical risk factor of post-
AMI cardiac death, it will be necessary to demonstrate that a reduc-
tion of this index improves clinical outcomes; however, our obser-
vations suggest a potential effect of β-blockers in reducing λ25 s.
CONCLUSION
Among post-AMI patients, an increase in non-Gaussianity index
of λ25 s is independently associated with increased risk of cardiac
death.Our observations suggest that the increasedλ25 s may reﬂect
the deleterious effects of heightened sympathetic cardiac activa-
tion, which may contribute to the increased risk of cardiac death
in post-AMI patients.
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APPENDIX
REANALYSIS OF PREVIOUS OBSERVATIONS IN A COHORT STUDY OF
CONGESTIVE HEART FAILURE PATIENTS
In a previously study (Kiyono et al., 2008), we reported that non-
Gaussian index λ40 beat is an independent predictor of increased
risk for mortality in patients with congestive heart failure (CHF).
We studied 108 patients who were consecutively referred for eval-
uation or treatment of CHF. They underwent 24-h Holter ECG
monitoring prior to hospital discharge and were subsequently
followed up for 33± 17months. The Holter ECG was analyzed
to determine non-Gaussian index together with time and fre-
quency domain indices of heart rate variability (HRV), fractal
HRV measures, and heart rate turbulence.
In this previous study (Kiyono et al., 2008), we computed the
non-Gaussian index λ based on beat scale and we found that
the λ at a scale of 40 beats (λ40 beat) showed the best predictive
power for mortality. However, analyses based on beat scale could
be affected by both inter- and intra-individual differences in heart
rate.We therefore reanalyzed the same data based on time (s) scale.
Time series of R–R intervals were interpolated with cubic spline
function, resampled at 4Hz, and submitted to the algorithm for
estimating λ. Cox proportional hazards regression analysis was
performed to determine the relative mortality risk of the indices.
Then, we found that the λ at a scale of 25 s (λ25 s) was the best
independent predictor of both all-cause and cardiac mortality.
The predictive power of λ25 s was comparable to that of λ40 beat
for both all-cause and cardiac mortality and even after adjustment
for other predictors (Table A1).
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Table A1 | Associations of HRV indices with mortality risk in CHF patients.
Predictor SD All-cause death Cardiac death
Unadjusted Adjusted* Unadjusted Adjusted*
RR (95% CI)† P RR (95% CI)† P RR (95% CI)† P RR (95% CI)† P
SDNN, ms 35 0.9 (0.7–1.3) 0.69 1.2 (0.8–1.6) 0.39 0.9 (0.7–1.3) 0.55 1.1 (0.8–1.6) 0.52
LnVLF 1.2 1.2 (0.9–1.6) 0.31 1.2 (0.9–1.6) 0.30 1.1 (0.8–1.6) 0.41 1.1 (0.8–1.6) 0.42
DFAα1 0.25 1.2 (0.9–1.6) 0.30 1.3 (0.9–1.8) 0.11 1.2 (0.8–1.6) 0.36 1.3 (0.9–1.9) 0.14
DC, ms 1.7 1.2 (0.8–1.6) 0.34 1.2 (0.8–1.6) 0.39 1.2 (0.9–1.8) 0.23 1.2 (0.9–1.8) 0.27
Abnormal HRT 1.6 (0.8–3.0) 0.15 1.4 (0.7–2.6) 0.31 1.6 (0.8–3.) 0.17 1.4 (0.7–2.7) 0.35
λ40 beat 0.16 1.6 (1.2–2.2) 0.001 1.5 (1.1–2.0) 0.005 1.6 (1.2–2.1) 0.003 1.4 (1.1–1.9) 0.01
λ25 s 0.16 1.6 (1.2–2.1) 0.001 1.5 (1.1–2.0) 0.003 1.6 (1.2–2.1) 0.002 1.5 (1.1–2.0) 0.01
CI, conﬁdence interval; DC, deceleration capacity; DFA, detrended ﬂuctuation analysis; HRT, heart rate turbulence; lnVLF, logarithm of the power of very-low frequency
component; RR, relative risk; SD, standard deviation; SDNN, SD of normal-to-normal R–R intervals during 24 h.
∗Adjusted for risk score that is the weighted sum of independent predictors of age, presence of ischemia, and natural logarithm of brain natriuretic protein level
(Kiyono et al., 2008).
†RR for 1 SD decrement in SDNN, LnVLF, and DC, and for 1 SD increment in DFA α1, λ25 s, and for the presence of abnormal HRT.
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